IBM Maximo for Life Science
Xybion’s IBM Maximo Solutions team provides industry specific capabilities to support life science and pharmaceutical manufacturing business requirements. We are industry-recognized specialists in implementing and supporting IBM Maximo when deployed in pharmaceutical manufacturing environments. With expertise in FDA guidelines and regulatory compliance challenges such as 21 CFR part 11 (for support of electronic signatures and electronic audits), calibration of instruments, tools & measurement equipment and standards, support for asset-related CAPA processes as well as extensive computer system validation expertise, the Stelex™ EAM Solutions team provides a unique life science solution for IBM Maximo.
The Stelex team brings deep domain expertise on implementing, managing and maintaining your Maximo EAM in a the highly regulated life sciences industry sector. Asset management is often tied to quality, compliance and risk management. Management of assets that are heavily regulated as part of the overall life science drug development and manufacturing process include:
Our specific offerings for Life Sciences include:
Learn More about Xybion's Maximo Solutions